Abstract 9081: Myocardial Infarction Mortality Trends in Patients with Heart Failure: A Retrospective Analysis from 1999-2024
Abstract
Introduction: Heart Failure (HF) with underlying Myocardial infarction (MI) is a major contributor to cardiovascular mortality, with both conditions constituting a growing public health and financial burden in the United States. While overall mortality has declined substantially, this reduction varies considerably in magnitude and trajectory across demographic and geographic subgroups, highlighting the necessity to identify persistently disadvantaged populations. Aim: Given persisting disparities in cardiovascular outcomes, we seek to assess long-term HF mortality trends among adults with a history of MI to inform targeted public health priorities. Methods: Data were extracted from CDC WONDER for adults aged >45 from 1999 to 2024, using ICD-10 code I21 as the underlying cause of death for MI and I50, identified via the MCD-ICD-10 113 Cause List, for HF. Age-adjusted mortality rates (AAMR) were computed per 100,000 and stratified by age, sex, race, urbanization, and census region. Joinpoint regression software was employed to estimate annual percent change (APC) and average annual percent change (AAPC) with 95% confidence intervals (CI) to define temporal mortality trends. Results: Over the study period, 409,552 HF-related deaths associated with MI were documented, with overall AAMR declining from 23.3 in 1999 to 9.4 in 2024 (AAPC: -3.63; 95% CI: -4.52 to -2.74). The steepest decline occurred between 2003-2010 (APC: -7.18), with a non-significant increase from 2018-2021 (APC: +2.96). Males endured persistently higher mortality than females, though females experienced a more pronounced decline (AAPC: -4.10 vs. -3.41). Adults aged 65+ demonstrated consistently higher mortality with a sharper downward trajectory compared to the 45-64 group (AAPC: -3.90 vs. -1.26). White individuals had the most substantial decline among all racial groups (AAPC: -3.54). By the end of the study period, the South had the highest regional AAMR (10.8), while the Northeast maintained the most overall reduction (AAPC: -4.38). Nonmetropolitan areas consistently exceeded metropolitan mortality, with a comparatively subdued decline (AAPC: -3.21 vs. -4.19). Conclusion: Despite a continuous decline in HF with underlying MI-related mortality from 1999 to 2024, males, Black or African American individuals, and Southern and rural populations shoulder a disproportionate residual burden, revealing significant disparities requiring equitable, population-specific public health interventions.